Fresenius Medical Care AG

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Net Income $673.4m $499.0m $537.9m $978.4m
Net Income From Continuing Operations $894.3m $732.5m $740.9m $1.2b
Adjustments For Depreciation And Amortisation Expense And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss $789.6m $1.6b $1.8b $1.6b $1.8b $1.8b $1.7b $1.5b
Depreciation $1.8b $1.8b $1.7b $1.5b
Depreciation Amortization Depletion $1.8b $1.8b $1.7b $1.5b
Deferred Income Tax ($41.5m) ($122.1m) ($72.7m) ($27.2m)
Deferred Tax ($41.5m) ($122.1m) ($72.7m) ($27.2m)
Adjustments For Share-Based Payments $27.4m $46.8m $10.7m $2.0m
Adjustments For Income Tax Expense $547.2m $654.2m $515.0m $380.1m
Earnings (Loss)es From Equity Investments ($66.6m) ($121.8m) ($134.9m) ($181.4m)
Additional Financial Items
Adjustments For Decrease Increase In Trade Account Receivable ($241.9m) ($181.3m) ($164.7m) ($105.8m)
General And Administrative Expense $2.4b $2.4b $2.4b
Goodwill $13.0b $12.1b $12.2b $14.0b $13.0b $14.4b $15.8b $14.7b $15.2b $13.6b
Interest Received Classified As Operating Activities $30.3m $35.5m $56.8m $49.5m $42.0m $73.2m $67.7m $88.2m $68.1m $68.2m
Payments Of Lease Liabilities Classified As Financing Activities $671.4m $649.0m
Payments To Acquire Or Redeem Entitys Shares $57.9m $37.2m $599.8m $366.0m $585.3m
Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets $116.9m $256.1m
Purchase Of Intangible Assets Classified As Investing Activities $12.2m $26.4m $85.1m $38.0m $33.2m $32.4m $46.3m $26.4m $8.5m $4.7m
Beginning Cash Position $1.5b $1.3b $1.4b $1.2b
Cash Flow From Continuing Financing Activities ($1.6b) ($1.9b) ($2.6b) ($1.4b)
Cash Flow From Continuing Investing Activities ($734.7m) ($544.2m) ($84.9m) ($722.5m)
Change In Account Payable ($356.8m) $108.5m $155.6m $12.4m
Change In Income Tax Payable $325.7m $472.1m $482.3m $236.6m
Change In Inventory ($204.3m) ($13.1m) $107.9m ($248.7m)
Change In Other Current Assets $154.0m $145.7m ($228.0m) $206.9m
Change In Payable ($31.1m) $580.6m $637.9m $249.1m
Change In Payables And Accrued Expense ($31.1m) $580.6m $637.9m $249.1m
Change In Receivables ($46.7m) ($151.8m) ($73.5m) ($69.1m)
Change In Tax Payable $325.7m $472.1m $482.3m $236.6m
Change In Working Capital ($128.1m) $561.3m $444.3m $138.2m
Changes In Account Receivables ($46.7m) ($151.8m) ($73.5m) ($69.1m)
Changes In Cash ($184.7m) $226.0m ($268.1m) $555.3m
End Cash Position $1.3b $1.4b $1.2b $1.6b
Financing Cash Flow ($1.6b) ($1.9b) ($2.6b) ($1.4b)
Free Cash Flow $1.4b $1.9b $1.7b $1.8b
Gain Loss On Sale Of PPE ($99.3m) ($12.9m) ($12.2m) $123.2m
Interest Received CFO $67.7m $88.2m $68.1m $68.2m
Investing Cash Flow ($734.7m) ($544.2m) ($84.9m) ($722.5m)
Net Business Purchase And Sale $1.0m $137.0m $606.7m $180.2m
Net PPE Purchase And Sale ($687.8m) ($668.5m) ($685.3m) ($898.7m)
Operating Gains Losses ($165.8m) ($134.7m) ($147.0m) ($58.1m)
Other Non Cash Items $292.5m $336.4m $335.5m $314.8m
Proceeds From Stock Option Exercised $6.5m $20.2m $0 $0
Purchase Of Business ($59.1m) ($35.2m) ($23.1m) ($22.0m)
Purchase Of PPE $944.5m $1.1b ($724.0m) ($684.6m) ($699.4m) ($915.4m)
Repurchase Of Capital Stock $0 $0 $0 ($585.3m)
Sale Of Business $60.2m $172.2m $629.7m $202.1m
Sale Of PPE $36.2m $16.1m $14.1m $16.7m
Profit or Loss $1.4b $1.6b $2.2b $1.4b $1.4b $1.2b $894.3m $732.5m $740.9m $1.2b
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $16.0m $103.2m $54.5m $11.5m $15.6m $24.4m $36.2m $16.1m $14.1m $16.7m
Capital Expenditure ($724.0m) ($684.6m) ($699.4m) ($915.4m)
Net Investment Purchase And Sale ($48.0m) ($12.8m) ($6.4m) ($4.0m)
Purchase Of Investment ($105.6m) ($102.4m) ($81.5m) ($87.5m)
Sale Of Investment $57.7m $89.6m $75.1m $83.5m
Cash flows from financing activities:
Issuance Of Debt $1.7b $483.2m $146.3m $1.8b
Long Term Debt Issuance $986.9m $417.9m $61.5m $1.6b
Net Issuance Payments Of Debt ($1.1b) ($1.2b) ($1.9b) $149.6m
Net Long Term Debt Issuance ($532.9m) ($1.0b) ($1.4b) $133.9m
Net Short Term Debt Issuance ($585.2m) ($179.6m) ($455.7m) $15.7m
Short Term Debt Issuance $717.1m $65.3m $84.8m $156.5m
Long Term Debt Payments ($1.5b) ($1.4b) ($1.5b) ($1.5b)
Repayment Of Debt ($2.8b) ($1.7b) ($2.1b) ($1.6b)
Short Term Debt Payments ($1.3b) ($245.0m) ($540.5m) ($140.8m)
Net Common Stock Issuance $0 $0 $0 ($585.3m)
Common Stock Payments $0 $0 $0 ($585.3m)
Dividends paid $244 $294 $325 $355 $351
Dividends Paid Classified As Financing Activities $244 $294 $325 $355
Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners $396 $329 $349 $423 $416
Cash Dividends Paid ($395.6m) ($328.6m) ($349.2m) ($422.5m)
Common Stock Dividend Paid ($392.5m) ($395.6m)
Dividend Received CFO $95.2m $220.0m $100.7m $139.2m
Net Other Financing Charges ($124.0m) ($340.1m) ($315.0m) ($545.0m)
Effect Of Exchange Rate Changes ($23.2m) ($72.6m) $26.2m ($141.5m)
Change In Cash Supplemental As Reported ($207.9m) $153.4m ($241.9m) $413.8m
Interest Paid Classified As Operating Activities $349.7m $339.1m $312.0m $470.2m $380.0m $341.6m $350.7m $394.5m $381.2m $360.0m
Income Taxes Paid Refund Classified As Operating Activities $541.1m $674.6m $358.4m $387.7m $301.7m $345.1m $334.6m $410.1m $444.6m $225.8m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.